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1, Introduction 
The physiological function of mitochondria 
requires the transport of Pi across the inner mito- 
chondrial membrane for 3 main metabolic reactions: 
(1) Uptake of phosphate together with ADP for the 
synthesis of ATP within the matrix; (2) Exchange of 
phosphate against dicarboxylates for metabolite 
fluxes between cytosol and matrix; (3) Uptake and 
release of phosphate together with Ca* for calcium 
homeostasis in the cytoplasm [I]. For these functions 
4 separate phosphate transport systems have been 
described in mitochondria which could only be dif- 
ferentiated by their sensitivity against SH-group 
~ibitors: (1) The electro~leutr~ phosphate~proton 
symporter is inhibited by MalNEt and low concen- 
trations of p-chloromercuribenzoate nd mersalyl 
[2-4]; (2) The electroneutral dicarboxylate anti- 
porter, exchanging dicarboxylates or phosphate 
against each other, is inhibited by p-chloromercuri- 
benzoate, mersalyl and the dicarboxylate analogon 
butyimalonate, but not by MalNEt [S-7]; (3) The 
electrogenic phosphate uniporter is i~ibited by 
mersalyl [S] and with inverted inner membrane vesi- 
cles by p-chloromercuribenzoate nd MalNEt [9]; (44) 
The electrogenic calcium/phosphate symporter was 
found insensitive against MalNEt and mersaylyl 
[lo,1 11. The latter transport system, however, does 
not seem to represent aseparate transporter, because 
the ~sensiti~ty against MalNEt and ~-c~oromercu~- 
benzoate could not be corroborated [12,13]. 
The simultaneous occurrence of the electroneutral 
phosphate/proton symporter (phosphate uptake) and 
the electrogenic phosphate uniporter (phosphate 
Abbreviations: PMS, p-chloromercuri phenylsulfonate; 
MalNEt, N-ethylmaleimide; SDS, sodium dodecylsulfate 
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release) in mitochondria, would result in a futile cycle, 
driven by the mitochondrial proton pump. Therefore 
a strong regulation of the phosphate transport system 
has to be assumed. The existence of only one regulated 
transport system which functions either as proton/ 
phosphate symporter or as phosphatejdicarboxylate 
antiporter has also been suggested [ 14-161. Here the 
effect of the antiseptic e~y~ercu~~os~cylate 
(thiomersal), which contains ulfur and mercury in a 
covalent linkage, on the phosphate uptake of mito- 
chondria is described. The data suggest a regulated 
sensitivity of the phosphate/proton symport against 
SH-inhibitors. 
2. Materials and methods 
MalNEt, thiomersal and thiosalicylic acid were 
purchased from Serva (Heidelberg), PMS and rotenone 
from Sigma (St Louis). [32P] Phosphate and r3H] - 
sucrose (3 Ci/mmol) were obtained from Amersham 
Buchler. Ail other chemicals were of analytical grade. 
Rat liver mitochond~a were isolated by standard 
procedures [ 171. Swelling of mitochondria was done 
as in [ 161, either in 100 mM ammonium phosphate 
(pH 7.3), 2 mM EDTA and 1 MM rotenone (A), or in 
80 mM potassium phosphate (pH 7.3), 40 mM 
ammonium chloride, 1 PM rotenone (B). The uptake 
of [32P]phosphate was measured in aliquots (800 ~1) 
taken from cuvettes ~nt~~g 2 ml swelling medium 
(B) and 0.2 ErCi [3zP]phosphate plus 2 @i [3H]- 
sucrose, at the indicated times after addition of mito- 
chondria. After centrifugation for 30 s in an Eppen- 
dorf centrifuge the supernatant was immediately 
removed and the pellet dissolved in 300 fl2% SDS 
and counted in IO ml scintillation fluid. Protein was 
determined by the biuret method f 181. 
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3. Results 
Thiomersal alone has almost no influence on the 
uptake of phosphate into rat liver mitochondria, as 
measured by the swelling rate in isotonic ammonium 
phosphate. Only 10% inhibition is found with 110 
nmol thiomersal/mg mitochondrial protein and 16% 
with 220 nmol/mg (not shown), Preincubation of 
mitochondria with PMS (27 nmol/mg) leads to com- 
plete inhibition of swelling, which can be abolished 
by addition of thiomersal(32 nmol/mg) as shown in 
fig.lB. After a short lag-phase the final swelling rate is 
even higher than in the control (fig.lA). To exclude 
the possibility that thiomersal might have displaced 
PMS from the functional SH-group by forming a 
complex with it, excess PMS was added to the thio- 
mersal activated mitochondria (fig.lC). No change of 
the activated swelling rate was observed, although 
the amount of PMS (42 nmol/mg) exceeded the 
amount of thiomersal(8.5 nmol/mg). This result 
also excludes the possibility that thiosalicylate, which 
might have been formed from thiomersal by trans- 
mercaptization, released the inhibition by reaction 
with PMS. Excess thiosalicylate, like many other SH- 
compounds, can release the inhibition of swelling by 
PMS (fig.lD). 
Since PMS reacts reversibly with the phosphate 
carrier SH-group, it could not be excluded that thio- 
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Fig.1. Effect of thiomersal (TM) and thiosalicylate (TS) on 
the swelling of PMS-inhibited mitochondria in ammonium 
phosphate. Swelling was measured in medium B (see sec- 
tion 2). (A) Control without inhibitor. (B) Mitochondria 
were preincubated for 1 min at 0°C with 27 nmol PMS/mg; 
addition, 36 nmol thiomersal/mg. (C) Preincubation as in (B) 
with 21 nmol PMS/mg; additions, 8.5 nmol thiomersal/mg 
and 21 nmol PMS/mg. (D) Preincubation as in (C); additions, 
61 nmol thiosalicylate/mg. 




Fig.2. Effect of thiomersal (TM) and thiosalicylate (TS) on 
the swelling of MalNEt-inhibited mitochondria in ammonium 
phosphate. Swelling was measured in medium B (see sec- 
tion 2). (A) Control without inhibitor. (B) Mitochondria 
were preincubated for 1 min at 0°C with 32 nmol MalNEt/ 
mg; addition, 11 nmol thiomersal/mg. (C) Preincubation as 
in (B); addition, 27 nmol thiomersal/mg. (D) Preincubation 
as in 0); addition, 32 nmol thiomersal/mg and 57 nmol 
thiosalicylate/mg. 
mersal might have influenced the binding of PMS to 
the SH-group in an unknown way. We therefore 
investigated the effect of thiomersal on MalNEt 
inhibited mitochondria. MalNEt is known to react 
irreversibly with SH-groups of proteins. In fig.2 the 
effect of thiomersal on the swelling of MalNEt 
inhibited mitochondria is shown. Similar to PMS- 
inhibited mitochondria thiomersal restores swelling 
to a similar rate (fig.2B) to that of the control (fig.2A). 
With 27 nmol/mg (fig.2C) the swelling rate is even 
higher than that obtained with 11 nmol thiomersal/ 
mg (fig.2B). If after the addition of thiomersal(l1 
nmol/mg) excess thiosalicylate (57 nmol/mg) is added, 
the reactivated swelling is inhibited again (fig.2C). 
This result may be explained by formation of a com- 
plex between thiomersal and thiosalicylate, which 
relieves the effect of thiomersal. In addition it clearly 
demonstrates that thiomersal did not remove the 
blockade of the functional SH-group by MalNEt, but 
instead reactivated the phosphate transport by a 
reversible change. 
The measurement of phosphate uptake in mito- 
chondria by the swelling method, although well 
established, is only an indirect method. In order to 
exclude that thiomersal induced an unspecific change 
of the absorbance of mitochondria, the uptake of 
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Fig.3. Correlation of swelling in ammonium phosphate with 
the uptake of [saP]phosphate in mitochondria. The swelling 
medium (B) contained in addition [3’P]phosphate and [sH]- 
sucrose. At the end of the swelling, as indicated in the figure, 
aliquots were taken and the [31P]phosphate uptake was 
estimated as in section 2 (see insert). (l-7) Mitochondr~ 
were pre~cubat~ for 1 min at 0°C with 32 nmol MalNEt/ 
mg; addition of thiomersaJ (TM) (nmoi/mg) where indicated: 
2 (12.4), 3 (17.8), 4 (20.9), 5 (23.3), 6 (31.0), 7 (46.5). (8) 
Control without inhibitor. 
phosphate was controlled with [32PJphosphate. In 
fig.3 the amount of ~32P]phosphate, taken up by the 
mitochondria during the swelling, is correlated with 
the change of absorbance at various concentrations of
thiomersal. Both the swelling of the control and that 
of MalNEt inhibited thiomersal-activated mitochon- 
dria, correspond to an equivalent amount of [““PI- 
phosphate taken up into the mitochondria. 
The ex~r~ents of fig.l-3 were performed with 
swelling medium B containing high concentrations of
potassium. Some organic mercurials are known, how- 
ever, to induce a potassium permeability in mito- 
chondria [ 191. In order to exclude that phosphate 
might have been taken up into mitochondria via an 
electrogenic phosphate transporter [9] together with 
potassium, the experiments were repeated in potas- 
sium-free swelling medium A. The results (not shown) 
were almost identical: thiomersal could restore the 
swelling of MalNEt-, PMB- or mersalyl-inhibited 
mitochondria. 
4. Discussion 
It is generally accepted that the phosphate/proton 
symporter of mitochondria contains one or two func- 
tional SH-groups, which are sensitive against MalNEt 
and some organic mercury compounds (reviewed 
[ZO]). The i~ibition of phosphate transport by 
MalNEt is suggested tobe irreversible, whereas that 
obtained with organic mercury compounds can be 
totally reversed by addition of SH-compounds like 
cysteine or mercaptoethanol. These data show a 
reactivation of MalNEt or PMS-inhibited phosphate 
transport by thiomersal. The inhibition of thiomersal- 
reactivated phosphate transport by ~os~cylate 
(fig.2D) excludes the possibility that thiomersal might 
have reversed the inhibition by reaction with MalNEt. 
Another possibility could be the induction of an 
unspecific anion permeability in mitochondria by 
thiomersal. This, however, seems rather improbable 
since pretreatment of mitochondria with 30 nmol 
thiomersallmg inhibits the uptake of malate, as 
measured by the swelling in isotonic malate 1211. The 
amount of phosphate taken up under swelling condi- 
tions in the presence of thiomersal (~120 nmoljmg) 
excludes the uptake of phosphate via the MalNEt- 
insensitive phosphate/dicarboxylate ntiporter, 
because there is no equivalent amount of dicar- 
boxylate anions in the mitochondria [22]. There are 
at least wo possib~ities to explain the uptake of phos. 
phate in the presence of PMS or Monet and thio- 
mersal. 
(1) Thiomersal activates alatent phosphate transport 
system of mitochondria which is different from 
the known phosphate transport systems. 
(2) It could be suggested that MalNEt and organic 
mercurials react with a SH-group of the phos- 
phate/proton symporter which is not directly 
involved in the transport process. 
The binding of the inhibitors causes ome changes in 
the carrier protein, resulting in inhibition of phos- 
phate transport. This change might be reversed by 
thiomersal without removing the SH-inhibitors. At 
present we cannot decide between the two possibili- 
ties. 
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